JP2023548118A5 - - Google Patents
Info
- Publication number
- JP2023548118A5 JP2023548118A5 JP2023526012A JP2023526012A JP2023548118A5 JP 2023548118 A5 JP2023548118 A5 JP 2023548118A5 JP 2023526012 A JP2023526012 A JP 2023526012A JP 2023526012 A JP2023526012 A JP 2023526012A JP 2023548118 A5 JP2023548118 A5 JP 2023548118A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- cells
- genetically modified
- administration
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063107992P | 2020-10-30 | 2020-10-30 | |
| US63/107,992 | 2020-10-30 | ||
| PCT/US2021/057363 WO2022094284A1 (en) | 2020-10-30 | 2021-10-29 | Methods of administering genetically modified b cells for in vivo delivery of therapeutic agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548118A JP2023548118A (ja) | 2023-11-15 |
| JP2023548118A5 true JP2023548118A5 (enExample) | 2024-11-06 |
Family
ID=81383286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023526012A Pending JP2023548118A (ja) | 2020-10-30 | 2021-10-29 | 治療剤のｉｎ ｖｉｖｏ送達のために、遺伝子改変Ｂ細胞を投与する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230414659A1 (enExample) |
| EP (1) | EP4236968A4 (enExample) |
| JP (1) | JP2023548118A (enExample) |
| CN (1) | CN116490203A (enExample) |
| AU (1) | AU2021368725A1 (enExample) |
| CA (1) | CA3196239A1 (enExample) |
| WO (1) | WO2022094284A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4709867A1 (en) * | 2023-05-08 | 2026-03-18 | The Regents of the University of California | Targeted viral transduction of b cells |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4659092B2 (ja) * | 2005-04-18 | 2011-03-30 | エーシーティーエックス，インコーポレイテッド | 損傷組織へのｂ細胞投与による組織機能の回復 |
| CN115120746A (zh) * | 2013-05-15 | 2022-09-30 | 明尼苏达大学董事会 | 腺相关病毒介导的基因向中枢神经系统转移 |
| DK3234107T3 (da) * | 2014-12-19 | 2022-10-17 | Immusoft Corp | B-celler til in vivo-levering af terapeutiske midler |
| CA3012195A1 (en) * | 2016-02-03 | 2017-08-10 | The Trustees Of The University Of Pennsylvania | Gene therapy for treating mucopolysaccharidosis type i |
| BR112019022473A2 (pt) * | 2017-04-27 | 2020-10-20 | Immusoft Corporation | células b para liberação in vivo de agentes terapêuticos e dosagens destas |
| US20210207167A1 (en) * | 2018-05-16 | 2021-07-08 | Voyager Therapeutics, Inc. | Aav serotypes for brain specific payload delivery |
| JP7675014B2 (ja) * | 2019-01-23 | 2025-05-12 | ザ ジェネラル ホスピタル コーポレイション | Ｂ細胞免疫療法 |
-
2021
- 2021-10-29 WO PCT/US2021/057363 patent/WO2022094284A1/en not_active Ceased
- 2021-10-29 EP EP21887642.3A patent/EP4236968A4/en active Pending
- 2021-10-29 US US18/034,865 patent/US20230414659A1/en active Pending
- 2021-10-29 AU AU2021368725A patent/AU2021368725A1/en active Pending
- 2021-10-29 JP JP2023526012A patent/JP2023548118A/ja active Pending
- 2021-10-29 CA CA3196239A patent/CA3196239A1/en active Pending
- 2021-10-29 CN CN202180074274.3A patent/CN116490203A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI908706B (zh) | ＣＡＲＴｙｒｉｎ組成物和使用方法 | |
| Ghosh et al. | T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations | |
| CN102271702B (zh) | 抗第三方中枢记忆性t细胞、产生其的方法及其在移植和疾病治疗中的用途 | |
| US20220047637A1 (en) | Systems and methods for the treatment of hemoglobinopathies | |
| JP2020509780A (ja) | 細胞並びにその使用方法及び製造方法 | |
| JP2020517692A5 (enExample) | ||
| JP6750782B2 (ja) | 移植用幹細胞及びその製造方法 | |
| JP6894652B1 (ja) | 組織修復剤、組織修復剤の使用方法およびスクリーニング方法 | |
| CN101072866A (zh) | 通过施用rna改变细胞性质的方法 | |
| Leong et al. | Surface tethering of inflammation-modulatory nanostimulators to stem cells for ischemic muscle repair | |
| JP2013040204A (ja) | コポリマー１と組み合わせた、神経発生の誘発及び幹細胞治療 | |
| CN106167789B (zh) | 低氧处理的间充质干细胞及其应用 | |
| JP2023138660A5 (enExample) | ||
| JP2021515576A5 (enExample) | ||
| US12325735B2 (en) | Regulatory T cells genetically modified for the lymphotoxin alpha gene and uses thereof | |
| JPH09508116A (ja) | 末梢血単核細胞溶解活性を刺激するためのｉｌ−１０の使用 | |
| JP2003526685A (ja) | 腫瘍治療用の全身性遺伝子送達運搬体 | |
| CN116171158A (zh) | 细胞因子风暴抑制剂、细胞因子风暴抑制剂的使用方法和筛选方法 | |
| JP2023548118A5 (enExample) | ||
| CN115175990A (zh) | 治疗血红蛋白病的经修饰的细胞和方法 | |
| Alton et al. | Progress and prospects: gene therapy clinical trials (part 2) | |
| JP2025032034A (ja) | 若返り剤および若返り方法 | |
| US20220290157A1 (en) | Compositions and methods for treating amyotrophic lateral sclerosis | |
| US20240083973A1 (en) | T cells modified to express mutated cxcr4 or partially deleted and uses thereof | |
| EP4060026A1 (en) | Ex-vivo proliferation of human phagocytic cells |